FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004041780> ?p ?o ?g. }

• W2004041780 endingPage "1429" @default.
• W2004041780 startingPage "1419" @default.
• W2004041780 abstract "The inhibitory effects of glabridin, an isoflavan isolated from licorice (Glycyrrhiza glabra) root, and its derivatives on the oxidation of LDL induced by copper ions or mediated by macrophages were studied, in order to evaluate the contribution of the different parts of the isoflavan molecule to its antioxidant activity. The peak potential (E1/2) of the isoflavan derivatives, their radical scavenging capacity toward 1,1-diphenyl-2-picryl-hydrazyl (DPPH) radical and their ability to chelate heavy metals were also analyzed and compared to their inhibitory activity on LDL oxidation. In copper ion-induced LDL oxidation, glabridin (1), 4'-O-methylglabridin (2), hispaglabridin A (3), and hispaglabridin B (4), which have two hydroxyl groups at positions 2' and 4' or one hydroxyl at position 2' on ring B, successfully inhibited the formation of conjugated dienes, thiobarbituric acid reactive substances (TBARS) and lipid peroxides, and inhibited the electrophoretic mobility of LDL under oxidation. Compounds 1-3 exhibited similar activities, whereas compound 4 was less active. In macrophage-mediated LDL oxidation, the TBARS formation was also inhibited by these isoflavans (1-4) at a similar order of activity to that obtained in copper ion-induced LDL oxidation. On the other hand, 2'-O-methylglabridin (5), a synthesized compound, whose hydroxyl at 2'-position is protected and the hydroxyl at 4'-position is free, showed only minor inhibitory activity in both LDL oxidation systems. 2',4'-O-Dimethylglabridin (6), whose hydroxyls at 2'- and 4'-positions are both protected, was inactive. Resorcinol (7), which is identical to the phenolic B ring in glabridin, presented low activity in these oxidation systems. The isoflavene glabrene (8), which contains an additional double bond in the heterocyclic C ring, was the most active compound of the flavonoid derivatives tested in both oxidation systems. The peak potential of compounds 1-5 (300 microM), tested at pH 7.4, was similar (425-530 mV), and that for compound 6 and 8 was 1078 and 80 mV, respectively. Within 30 min of incubation, compounds 1, 2, 3, 4, 8 scavenged 31%, 16%, 74%, 51%, 86%, respectively, of DPPH radical, whereas compounds 5 and 6, which almost did not inhibit LDL oxidation, also failed to scavenge DPPH. None of the isoflavan derivatives nor the isoflavene compound were able to chelate iron, or copper ions. These results suggest that the antioxidant effect of glabridin on LDL oxidation appears to reside mainly in the 2' hydroxyl, and that the hydrophobic moiety of the isoflavan is essential to obtain this effect. It was also shown that the position of the hydroxyl group at B ring significantly affected the inhibitory efficiency of the isoflavan derivatives on LDL oxidation, but did not influence their ability to donate an electron to DPPH or their peak potential values." @default.
• W2004041780 created "2016-06-24" @default.
• W2004041780 creator A5007531628 @default.
• W2004041780 creator A5035610260 @default.
• W2004041780 creator A5052487247 @default.
• W2004041780 creator A5070960442 @default.
• W2004041780 date "1998-06-01" @default.
• W2004041780 modified "2023-10-17" @default.
• W2004041780 title "Structural Aspects of The Inhibitory Effect of Glabridin on LDL Oxidation" @default.
• W2004041780 cites W1261198562 @default.
• W2004041780 cites W1481440066 @default.
• W2004041780 cites W1503465979 @default.
• W2004041780 cites W1552240535 @default.
• W2004041780 cites W1574544450 @default.
• W2004041780 cites W1590457525 @default.
• W2004041780 cites W165553398 @default.
• W2004041780 cites W1775749144 @default.
• W2004041780 cites W1810073570 @default.
• W2004041780 cites W1841006369 @default.
• W2004041780 cites W1857052429 @default.
• W2004041780 cites W1869991540 @default.
• W2004041780 cites W1969191668 @default.
• W2004041780 cites W1972859758 @default.
• W2004041780 cites W1979655335 @default.
• W2004041780 cites W1989708266 @default.
• W2004041780 cites W1997371891 @default.
• W2004041780 cites W2000189967 @default.
• W2004041780 cites W2001628109 @default.
• W2004041780 cites W2005182309 @default.
• W2004041780 cites W2007470809 @default.
• W2004041780 cites W2007859845 @default.
• W2004041780 cites W2009288654 @default.
• W2004041780 cites W2011199541 @default.
• W2004041780 cites W2020967224 @default.
• W2004041780 cites W2024754142 @default.
• W2004041780 cites W2029416355 @default.
• W2004041780 cites W2030880582 @default.
• W2004041780 cites W2031596649 @default.
• W2004041780 cites W2034488492 @default.
• W2004041780 cites W2035605859 @default.
• W2004041780 cites W2041305220 @default.
• W2004041780 cites W2051130920 @default.
• W2004041780 cites W2057889917 @default.
• W2004041780 cites W2082296321 @default.
• W2004041780 cites W2086959952 @default.
• W2004041780 cites W2087075582 @default.
• W2004041780 cites W2091685154 @default.
• W2004041780 cites W2094890404 @default.
• W2004041780 cites W2095014890 @default.
• W2004041780 cites W2144483204 @default.
• W2004041780 cites W2146346788 @default.
• W2004041780 cites W2153473625 @default.
• W2004041780 cites W2164931507 @default.
• W2004041780 cites W2508524348 @default.
• W2004041780 cites W3022864527 @default.
• W2004041780 cites W4247070095 @default.
• W2004041780 doi "https://doi.org/10.1016/s0891-5849(98)00006-9" @default.
• W2004041780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9641259" @default.
• W2004041780 hasPublicationYear "1998" @default.
• W2004041780 type Work @default.
• W2004041780 sameAs 2004041780 @default.
• W2004041780 citedByCount "111" @default.
• W2004041780 countsByYear W20040417802012 @default.
• W2004041780 countsByYear W20040417802013 @default.
• W2004041780 countsByYear W20040417802014 @default.
• W2004041780 countsByYear W20040417802015 @default.
• W2004041780 countsByYear W20040417802016 @default.
• W2004041780 countsByYear W20040417802017 @default.
• W2004041780 countsByYear W20040417802019 @default.
• W2004041780 countsByYear W20040417802020 @default.
• W2004041780 countsByYear W20040417802021 @default.
• W2004041780 countsByYear W20040417802022 @default.
• W2004041780 countsByYear W20040417802023 @default.
• W2004041780 crossrefType "journal-article" @default.
• W2004041780 hasAuthorship W2004041780A5007531628 @default.
• W2004041780 hasAuthorship W2004041780A5035610260 @default.
• W2004041780 hasAuthorship W2004041780A5052487247 @default.
• W2004041780 hasAuthorship W2004041780A5070960442 @default.
• W2004041780 hasConcept C155647269 @default.
• W2004041780 hasConcept C178790620 @default.
• W2004041780 hasConcept C185592680 @default.
• W2004041780 hasConcept C2776778087 @default.
• W2004041780 hasConcept C2777352226 @default.
• W2004041780 hasConcept C2778004101 @default.
• W2004041780 hasConcept C2780829032 @default.
• W2004041780 hasConcept C2994476132 @default.
• W2004041780 hasConceptScore W2004041780C155647269 @default.
• W2004041780 hasConceptScore W2004041780C178790620 @default.
• W2004041780 hasConceptScore W2004041780C185592680 @default.
• W2004041780 hasConceptScore W2004041780C2776778087 @default.
• W2004041780 hasConceptScore W2004041780C2777352226 @default.
• W2004041780 hasConceptScore W2004041780C2778004101 @default.
• W2004041780 hasConceptScore W2004041780C2780829032 @default.
• W2004041780 hasConceptScore W2004041780C2994476132 @default.
• W2004041780 hasIssue "9" @default.
• W2004041780 hasLocation W20040417801 @default.
• W2004041780 hasLocation W20040417802 @default.
• W2004041780 hasOpenAccess W2004041780 @default.

• next